Cantitate/Preț
Produs

Lung Cancer

Editat de Heine H. Hansen
en Limba Engleză Paperback – 11 oct 2012
Primary lung tumors are now a global health problem. The incidence has risen dramatically during the last 5--6 decades, reflecting the popularity of cigarette smoking.
In this, the fifth volume dealing with lung cancer in the series KappaCANCER TREATMENT AND RESEARCHkappa, many current research topics are covered by notable authorities, including chemoprevention, growth factors, multidrug resistance, new agents, and haematopoietic growth factors.
Altogether, the 17 chapters from twelve countries highlight some of the rapid developments taking place in basic and clinical research of lung cancer. These chapters not only give up-to-date information, they will also stimulate further research into this man-made disease which was almost unheard of a century ago.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (3) 34599 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 2 oct 1990 34599 lei  6-8 săpt.
  Springer Us – 4 oct 2011 105141 lei  6-8 săpt.
  Springer – 11 oct 2012 336338 lei  6-8 săpt.
Hardback (2) 105882 lei  6-8 săpt.
  Springer Us – 30 apr 1986 105882 lei  6-8 săpt.
  Springer Us – 31 dec 1994 336035 lei  6-8 săpt.

Preț: 336338 lei

Preț vechi: 354040 lei
-5%

Puncte Express: 5045

Preț estimativ în valută:
59490 70541$ 51831£

Carte tipărită la comandă

Livrare economică 25 martie-08 aprilie


Specificații

ISBN-13: 9781461361282
ISBN-10: 1461361281
Pagini: 420
Ilustrații: XI, 404 p.
Dimensiuni: 155 x 235 x 23 mm
Greutate: 0.63 kg
Ediția:1995
Editura: Springer
Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

1. Tobacco consumption and lung cancer.- 2. Lung cancer chemoprevention.- 3. Smoking cessation programs.- 4. Genetics of lung cancer: implications for early detection and prevention.- 5. Growth factors and lung cancer.- 6. The development and progression of adenocarcinoma of the lung.- 7. Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis.- 8. In vivo models for testing of cytostatic agents in non-small cell lung cancer.- 9. In vitro models for testing of cytostatic agents in small cell lung cancer.- 10. Multidrug resistance in lung cancer.- 11. New techniques in the diagnosis and staging of lung cancer.- 12. The role of chest irradiation in small cell lung cancer.- 13. The role of hematopoietic growth factors in small cell lung cancer: a review.- 14. Interferon and lung cancer.- 15. New antineoplastic agents in lung cancer 1988–1993.- 16. Pulmonary blastomas.- 17. Psychosocial issues in lung cancer patients.